News

Nasdaq1d
Is Apple Stock a Bad-News Buy?
Shares of tech and consumer giant Apple (NASDAQ: AAPL) are down around 20% this year. That's not the type of performance ...
Will Musk’s Focus and Robotaxi Hype Drive Tesla’s Next Rally?
Tesla stock (NASDAQ:TSLA) has gained close to 20% over the past month. This rally is partly driven by a broader market upswing, but a more crucial factor has been CEO Elon Musk’s renewed focus on ...
The 2025 Intern’s Guide to the Market Structure Galaxy
Investors provide capital to companies, which then provide dividends and returns to investors. Banks help investors value stocks, while exchanges allow traders to provide liquidity and arbitrageurs to ...
Nasdaq Global Retail Executive Forum Rings the Closing Bell
About This EventThe 2025 Global Retail Executive Forum visits the Nasdaq MarketSite in Times Square. The event brings together industry leaders from across the globe to share insights and discuss the ...
Care.com Rings the Opening Bell
About This EventCare.com (Nasdaq: IAC), one of the largest online marketplaces to find family care and care jobs, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Brad Wilson, ...
Billionaire Stanley Druckenmiller Sold Palantir and Amazon and Is Piling Into This Artificial Intelligence (AI) Stock Instead
Back in 2022, billionaire Stanley Druckenmiller made a sizable bet on chipmaker Nvidia. The company has gone on to become one ...
How BioArctic Is Transforming Alzheimer’s Research
Oskar Bosson, VP and Head of Investor Relations and Communications at BioArctic, shares the company’s mission to combat neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. Oskar ...
Healthy Equity Markets Boost Economic Growth
So, for all countries, they find that a 10% increase in the market cap ratio leads to a 0.028% increase in long-run economic growth, while for high-income countries alone, it leads to a 0.045% ...
Nasdaq Verafin and Fincom Partner to Strengthen Sanctions Screening Capabilities
Nasdaq Verafin is embarking on a strategic collaboration with sanctions screening provider Fincom to bring more robust sanctions screening technology to clients. Sanctions screening is an ...
Gubra’s Innovation in Peptide-Based Drug Discovery
Gubra is a highly specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. In this interview, CEO Henrik Blou reflects on Gubra’s ...
Bridge 2 Technologies Rings the Closing Bell
About This EventBridge 2 Technologies, a global next-generation technology company that is changing the way businesses engage around the world and delivers actionable results that will positively ...